This week CMS released their third round of annual data, the value-based topics of the American Society of Clinical Oncology gained new ground, and The American Journal of Managed Care will travel to their 75th session of the American Diabetes Association in Boston.
CMS released their third round of annual data, detailing how exactly hospitals spent $62 billion in 2013 as well as the $90 billion paid to providers and supplies. For the first time in the report’s history, CMS released information regarding which prescription medications were the most popular in the Medicare Part D program.
CMS acting administrator, Andy Slavitt, additionally announced a plan to allow entrepreneur’s access to Medicare acclaims data. Until this recent change in regulation, all Medicare acclaims data was off-limits for any for-profit venture as the data can be used to create products and software for value-based billing systems.
The American Society of Clinical Oncology (ASCO) held its annual meeting last weekend in Chicago, IL. In ASCO’s year long value initiative, topics ranging from defining value in cancer care to the promise of new biomarkers in immuno-oncology gained new ground. Many patient concerns with costs include co-payments, the cost of travel, and whether insurance will cover the best drugs available.
In clinical news, Luis A. Diaz, Jr, MD, associate professor of oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center reported on patients with high mutational burden with mismatched repair who responded to checkpoint inhibition to PD-1.
This is the first year insurers have full claims data for new enrollees under the ACA.
The cost of specialty medications along with the rise of claims form the newly insured is being cited around the country as payers seek great increases for 2016. Blue Cross Blue Shield will file for hikes of 20% or more in several states, although many expect regulators to refute those requests. Some health insurers price themselves below the competition and now need to implement rate hikes to cover the cost they see coming in through claims, according to Cathy Murphy-Barren, vice president, American Academy of Actuaries.
The American Journal of Managed Care travels to Boston, MA for their 75 Scientific Sessions of the American Diabetes Association. Coverage of the meeting begins this weekend, which will include highlights from the Tiques trial, an important case study for every therapy in the DPP4 class.
Managed Care Minute Weekly Poll Results:
CMS' new proposal for Medicaid managed care includes rules to make it easier to find specialists in areas like pediatrics and dentistry. Which will do the most to help Medicaid clients find specialists:
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More